COLONEL KARL E. FRIEDL (RET.) JOINS PARKINSON'S ACTION NETWORK BOARD OF DIRECTORS

WASHINGTON, D.C.; JANUARY 3, 2013 – Colonel Karl E. Friedl (Ret.), former Director of the U.S. Army Medical Research & Materiel Command’s Telemedicine and Advanced Technology Research Center (TATRC), has joined the board of directors of the Parkinson’s Action Network (PAN).  As TATRC Director, Friedl oversaw the Neurotoxin Exposure Treatment Parkinson’s Research (NETPR) program, which examines how best to protect military personnel from toxic substances, head injury, and other possible contributors to Parkinson’s disease.

“Colonel Friedl is an important addition to the PAN Board of Directors because not only did he oversee a critically important research function at the Department of Defense, he also has been a champion of the Parkinson’s community and PAN for years,” said PAN CEO Amy Comstock Rick.  “He has spoken at many PAN events, sharing information on the latest discoveries with our advocates and inspiring researchers just starting out in their field, and he regularly educates policymakers and elected officials about the need for federal investment in biomedical research.  We welcome his perspective and expertise in our efforts to educate and promote strong federal funding and policy support for the 500,000 to 1.5 million Americans with Parkinson’s,” she added.

Colonel Friedl earned his B.A. (Zoology), M.A. (Zoology), and Ph.D. (Physiology) from the University of California at Santa Barbara, completing his research training in the University’s Institute of Environmental Stress.  He is an ROTC Distinguished Military Graduate and entered the Army in 1983 as a Captain in the Medical Service Corps.

Prior to being named TATRC Director, Friedl directed major initiatives including the Defense Women’s Health Research Program, Department of Defense Gulf War Illnesses, and Bone Health and Military Medical Readiness.  He was also Director for the Military Operational Medicine (MOM) research program, where he established a coordinated plan of biomedical research on protection and enhancement of the Soldier.  

Between 1996 and 2003, he chaired the Tri-Service Joint Technical Coordinating Group (JTCG-5) for MOM, expanding inter-Service cooperation and collaborative projects with other agencies such as the Department of Veterans Affairs, National Institutes of Health, National Aeronautics and Space Administration, and Department of Agriculture.  He has published over 100 peer-reviewed research papers, and he has completed studies on human metabolic limits at Madigan Army Medical Center and the U.S. Army Research Institute of Environmental Medicine.

He has been honored with PAN’s 2012 Morris K. Udall Award for Public Service, Society of Armed Forces Medical Laboratory Scientists Outstanding R&D Scientist Award, Legion of Merit with oakleaf cluster, Order of Military Medical Merit, the 2012 Ronald and Nancy Reagan Research Award, and the Surgeon General’s “A” professional designator.

Colonel Friedl retired from the U.S. Army in December 2012 after 30 years of service.

#   #   #

About the Parkinson’s Action Network (PAN)
PAN is the unified voice of the Parkinson’s community advocating for better treatments and a cure.  In partnership with other Parkinson’s organizations and our powerful grassroots network, PAN educates the public and government leaders on better policies for research and an improved quality of life for people living with Parkinson’s.

 

MEDIA CONTACT:  Carol Blymire; [email protected]; 202.638.4101 x113